Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress, +687

The Lancet

UrologyRenal DiseaseRenal EventsRenal FunctionDiabetes +5

Treatment of Graves' Disease with Antithyroid Drugs in the First Trimester of Pregnancy and the Prevalence of Congenital Malformation

Ai Yoshihara, JaedukYoshimura Noh, Takuhiro Yamaguchi, +11

The Journal of Clinical Endocrinology & Metabolism

Serum Ferritin Is Associated With Visceral Fat Area and Subcutaneous Fat Area

Tomoyuki Iwasaki, Atsushi Nakajima, Masato Yoneda, +6

Diabetes Care

Clinicopathological features of 171 cases of primary thyroid lymphoma: a long‐term study involving 24 553 patients with Hashimoto’s disease

Natsuko Watanabe, Jaeduk Yoshimura Noh, Hiroto Narimatsu, +14

British Journal of Haematology

Lymphoid NeoplasiaHashimoto ’MedicineThyroid DiseaseTreatment Response +7

Antithyroid Drug-Induced Hematopoietic Damage: A Retrospective Cohort Study of Agranulocytosis and Pancytopenia Involving 50,385 Patients with Graves' Disease

Natsuko Watanabe, Hiroto Narimatsu, Jaeduk Yoshimura Noh, +7

The Journal of Clinical Endocrinology & Metabolism

Antithyroid Drug Treatment for Graves' Disease in Children: A Long-Term Retrospective Study at a Single Institution

Hidemi Ohye, Akinobu Minagawa, Jaeduk Yoshimura Noh, +8

Thyroid

Aldosterone and Not Plasminogen Activator Inhibitor-1 Is a Critical Mediator of Early Angiotensin II/ <i>N</i> ^G -Nitro- <scp>l</scp> -Arginine Methyl Ester-Induced Myocardial Injury

Eveline Oestreicher, D. Martinez-Vasquez, James R. Stone, +4

Circulation

Clinical Characteristics of Myeloperoxidase Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Caused by Antithyroid Drugs

Jaeduk Yoshimura Noh, S. Yasuda, Shotaro Sato, +11

The Journal of Clinical Endocrinology & Metabolism

Prevalence of Malignant Tumors and Adenomatous Lesions Detected by Ultrasonographic Screening in Patients with Autoimmune Thyroid Diseases

Koji Mukasa, Jaeduk Yoshimura Noh, You Kunii, +6

Thyroid

Comparison of Efficacy and Adverse Effects Between Methimazole 15 mg+Inorganic Iodine 38 mg/Day and Methimazole 30 mg/Day as Initial Therapy for Graves' Disease Patients with Moderate to Severe Hyperthyroidism

Shotaro Sato, Jaeduk Yoshimura Noh, Shiori Sato, +9

Thyroid